RETINALGENIX TECHNOLOGIES INC. Operating Lease, Right-of-Use Asset, Amortization Expense
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $1.28 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- RETINALGENIX TECHNOLOGIES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $642.00, a 0.31% increase year-over-year.
- RETINALGENIX TECHNOLOGIES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $642.00, a 0.16% increase year-over-year.
- RETINALGENIX TECHNOLOGIES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $640.00.
- RETINALGENIX TECHNOLOGIES INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $641.00.
- RETINALGENIX TECHNOLOGIES INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $2.56K, a 200.12% increase from fiscal 2024.
- RETINALGENIX TECHNOLOGIES INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $854.00.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $642.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.28K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $642.00 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | $2.56K 10-K · filed 2026-04-15 | ||
| 2025-06-30 | $640.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.28K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $641.00 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | $854.00 10-K · filed 2026-04-15 |